Redhill Biopharma
RDHL
12 hedge funds and large institutions have $37.9K invested in Redhill Biopharma in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
1.1% more ownership
Funds ownership: 0% → 1.1% (+1.1%)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
53% less capital invested
Capital invested by funds: $80.5K → $37.9K (-$42.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$16.3K |
| 2 |
SS
SBI Securities
Tokyo,
Japan
|
+$4.07K |
| 3 |
Morgan Stanley
New York
|
+$3.65K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$774 |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$416 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$57.2K |
| 2 |
GI
GAMMA Investing
Foster City,
California
|
-$3.07K |
| 3 |
FMP
Financial Management Professionals
Austin,
Texas
|
-$77 |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$22 |
RDHL Hedge Fund Activity: Q2 2025 in Review
12 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q2 2025, worth a combined $37.9K — down 53% from $80.5K a quarter earlier.
Fund positioning in RDHL was balanced in Q2 2025: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, adding an estimated $16.3K. The largest seller was Citadel Advisors, exiting entirely with an estimated $57.2K sold.
- 12 institutional investors held Redhill Biopharma (RDHL) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $37.9K of Redhill Biopharma stock for Q2 2025, down 53% quarter-over-quarter.
- 1 fund opened new Redhill Biopharma positions in Q2 2025 and 1 closed out, a net change of 0 holders.
- The largest Redhill Biopharma buyer in Q2 2025 was UBS Group, an estimated $16.3K added.
- The largest Redhill Biopharma seller in Q2 2025 was Citadel Advisors, an estimated $57.2K sold.
Based on aggregated 13F filings for Q2 2025.